NCT05538091
- Conditions
- Hedgehog Inhibitor, PARP Inhibitor, Platinum-Resistant Fallopian Tube Carcinoma, +1 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
Hedgehog Inhibitor
Explore clinical trials studying Hedgehog Inhibitor. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study